Ibogaine by David Dardashti Recommends Ibogaine Treatments to be Tailored to Individuals

MIAMI, April 9, 2021 /PRNewswire/ —¬†Mankind continues to struggle to discover the mysteries of the universe. The main issue at hand is that many of the prestigious solutions necessary to lead the universe into a greater tomorrow are difficult to come by. Ibogaine hydrochloride has proven to be the most effective treatment for opiate addiction, yet complications still arise. The main objective is finding an effective method that offers the most optimal recovery for each specific patient. The difficulty is most ibogaine providers do not take this into consideration. They simply have a one size fits all method of Ibogaine treatment. This involves simply dosing them based upon their weight, measuring the number of milligrams relative to kilograms. Ibogaine By David Dardashti has worked many years providing the most effective full treatment of ibogaine hydrochloride, having treated thousands of patients.

The treatment dose involves the use of dozens of protocols, regarding the patients physical, mental, and emotional wellbeing. Booster treatments are derived from our full treatments dose. Methods are expressed in the following ways. Ibogaine By David Dardashti has integrated many mathematical models, using principles of calculus, algebra, and statistics, used to effectively measure and predict the outcome of a single person’s reaction to the ibogaine. While there are many different calculations, the main algorithm is structured to integrate any outliers which may affect the necessary dosage.

The main approach goes as follows. The first thing to take into considerations is the overall physical well-being of the person being treated. The most important variable to consider is the specific type of opiates the person is currently on. In addition to this, incorporate the precise amount of drugs in their body, as well as the average duration of that dose. Next, move on to the general physical health of a person outside the parameters of drug addiction.

Take into consideration physical health conditions that may be occurring based upon a person’s age, physical health, and body type. Also look at the person’s medical charts to search for outside health issues, such as diabetes and hepatitis C.¬† Ibogaine By David Dardashti is continuing to optimize this method more effectively by having patients take necessary phlebotomy tests prior to treatment. This will be used to gain greater insight into precise levels of physical health regarding levels of iron, potassium, insulin, and testosterone.

Next, measure the dosage regarding a person’s mental and emotional wellbeing. This incorporates primary factors such as basic levels of depression and anxiety. Any form of trauma that may have occurred throughout a person’s life, in addition to the severity of the trauma. Taking into consideration other pre existing neurological conditions, such as Autism, Attention deficits, compulsions, as well as dozens of other psychological conditions. By following these guidelines, patients receive the most productive, comforting, and inspirational ibogaine treatment they can possibly have.

For each full treatment, microdose booster treatments. The dosage for the booster treatment is derived proportionately from the full treatment dose. In doing so, the clinic enhances the experience of the full treatment over the course of several days, without causing the person to feel any discomfort. These methods have proven to be successful to the degree of treating people on long-acting opiates, such as Suboxone, Methadone, and Subutex, without the initial taper using short acting opiates.


Level of importance

Time

Dose

Relevance of Condition

Age

5

8-10 days

X milligrams

Total Sum Evaluated

Drug/case

8

15 days

X milligrams

Total Sum Evaluated

Duration of Use

8

8-12 days

X milligrams

Total Sum Evaluated

Blood Pressure

1-3

8 days

X milligrams

Total Sum Evaluated

Heart rate

1

8 days

X milligrams

Total Sum Evaluated

Glucose Level

2

12-15 days

X milligrams

Total Sum Evaluated

Weight

3-5

8-12 days

X milligrams

Total Sum Evaluated

Height

2

8-12 days

X milligrams

Total Sum Evaluated

Health Conditions

1-5

10-21 days

X milligrams

Total Sum Evaluated

Psychological Health

2-5

12-15 days

X milligrams

Total Sum Evaluated

Behavioral Health

2-7

12-15 days

X milligrams

Total Sum Evaluated

Contact:
Gavriel Dardashti
786-930-1880

307090@email4pr.com

SOURCE Ibogaine By David Dardashti